The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development - Westphalen, Christoph Benedikt; Martins-Branco, D.; Beal, J. R.; Cardone, C.; Coleman, N.; Schram, A. M.; Halabi, S.; Michiels, S.; Yap, C.; André, F.; Bibeau, F.; Curigliano, G.; et al. (Annals of oncology, 2024)
Online verfügbar: 25. August 2024, Artikelversion: 24. Oktober 2024